Kramer JM - Search Results

1

National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance.

Kramer JM, Hammill B, Anstrom KJ, Fetterolf D, Snyder R, Charde JP, Hoffman BS, Allen LaPointe N, Peterson E. Kramer JM, et al. Am Heart J. 2006 Sep;152(3):454.e1-8. doi: 10.1016/j.ahj.2006.02.030. Am Heart J. 2006. PMID: 16923412

2

Multifaceted intervention to promote beta-blocker use in heart failure.

LaPointe NM, DeLong ER, Chen A, Hammill BG, Muhlbaier LH, Califf RM, Kramer JM. LaPointe NM, et al. Among authors: kramer jm. Am Heart J. 2006 May;151(5):992-8. doi: 10.1016/j.ahj.2005.06.038. Am Heart J. 2006. PMID: 16644320 Clinical Trial.

3

Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.

Allen LaPointe NM, Zhou Y, Stafford JA, Hernandez AF, Kramer JM, Anstrom KJ. Allen LaPointe NM, et al. Among authors: kramer jm. Am J Cardiol. 2009 Jun 1;103(11):1518-24. doi: 10.1016/j.amjcard.2009.01.363. Epub 2009 Apr 8. Am J Cardiol. 2009. PMID: 19463509

4

Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial.

Calvert SB, Kramer JM, Anstrom KJ, Kaltenbach LA, Stafford JA, Allen LaPointe NM. Calvert SB, et al. Among authors: kramer jm. Am Heart J. 2012 Apr;163(4):657-65.e1. doi: 10.1016/j.ahj.2012.01.019. Am Heart J. 2012. PMID: 22520532 Clinical Trial.

5

Evaluation of the dofetilide risk-management program.

Allen LaPointe NM, Chen A, Hammill B, DeLong E, Kramer JM, Califf RM. Allen LaPointe NM, et al. Among authors: kramer jm. Am Heart J. 2003 Nov;146(5):894-901. doi: 10.1016/S0002-8703(03)00409-5. Am Heart J. 2003. PMID: 14597941

6

Part I: Identifying holes in the safety net.

O'Shea JC, Kramer JM, Califf RM, Peterson ED. O'Shea JC, et al. Among authors: kramer jm. Am Heart J. 2004 Jun;147(6):977-84. doi: 10.1016/j.ahj.2004.03.001. Am Heart J. 2004. PMID: 15199343 Review. No abstract available.

7

Long-term clinical outcomes following coronary stenting.

Anstrom KJ, Kong DF, Shaw LK, Califf RM, Kramer JM, Peterson ED, Rao SV, Matchar DB, Mark DB, Harrington RA, Eisenstein EL. Anstrom KJ, et al. Among authors: kramer jm. Arch Intern Med. 2008 Aug 11;168(15):1647-55. doi: 10.1001/archinte.168.15.1647. Arch Intern Med. 2008. PMID: 18695078

8

Comparative effectiveness of beta-blockers in elderly patients with heart failure.

Kramer JM, Curtis LH, Dupree CS, Pelter D, Hernandez A, Massing M, Anstrom KJ. Kramer JM, et al. Arch Intern Med. 2008 Dec 8;168(22):2422-8; discussion 2428-32. doi: 10.1001/archinternmed.2008.511. Arch Intern Med. 2008. PMID: 19064824

9

Underuse of aspirin in a referral population with documented coronary artery disease.

Califf RM, DeLong ER, Ostbye T, Muhlbaier LH, Chen A, LaPointe NA, Hammill BG, McCants CB, Kramer JM. Califf RM, et al. Among authors: kramer jm. Am J Cardiol. 2002 Mar 15;89(6):653-61. doi: 10.1016/s0002-9149(01)02335-9. Am J Cardiol. 2002. PMID: 11897205

10

Patient-reported frequency of taking aspirin in a population with coronary artery disease.

Allen LaPointe NM, Kramer JM, DeLong ER, Ostbye T, Hammill BG, Muhlbaier LH, McCants CB, Chen A, Califf RM. Allen LaPointe NM, et al. Among authors: kramer jm. Am J Cardiol. 2002 May 1;89(9):1042-6. doi: 10.1016/s0002-9149(02)02272-5. Am J Cardiol. 2002. PMID: 11988192

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

314 results

Search Page